Prevention and Early Diagnosis: all other forms of Diabetes

Do you work in prevention and/or early diagnosis of diabetes and/or its associated complications?

Other forms of diabetes are defined as: Type 2 diabetes, gestational diabetes, maturity onset diabetes of the young (MODY), neonatal diabetes, Wolfram Syndrome and Alström Syndrome

This category recognises the impact of preventative initiatives to help people and their families and/or carers to live healthier lives and reduce the risk of developing diabetes, and of early diagnosis, and diabetes management initiatives for all other forms of diabetes to optimise outcomes and reduce complications.

Entries may be submitted by NHS organisations, charities, national bodies, CCGs, local authorities, schools, pharmacies and private/consumer brand initiatives operating at a locality, regional or national level.

Entries should demonstrate clear, specific goals with outcomes that have been evaluated using appropriate baseline and follow-up measures. There should be evidence of innovation, and detail of project planning, methods, safety considerations, effectiveness, timeliness, user feedback, cost efficiency and economic viability and evidence of potential/demonstrable sustainability and dissemination.

Entries to this category could include:

  • Diabetes awareness and promotion of healthy diet and lifestyle for the general population and for specific at risk groups, such as those with a family history of type 2 diabetes, previous gestational diabetes, people from more socially deprived areas and the BAME community
  • Life-threatening disease avoidance through initiatives which impact and lower risk of developing diabetes e.g. cardiovascular health, obesity interventions
  • Initiatives addressing health literacy
  • Increasing screening uptake or improving screening e.g. diagnosing diabetes. in optometrist practices, pharmacies, A&E, company health check initiatives
  • Use of diagnostic tools
  • Digital and technology initiatives to aid prevention, diagnosis or management of type 2 diabetes and/or associated complications: should be UK or Ireland based (even if they are used globally). Work must have been conducted during the 18-month period between July 2017 and December 2018
  • Local/regional/national initiatives aimed at improving care and outcomes for people diagnosed with type 2 or gestational diabetes e.g:
    • Psychological wellbeing initiatives addressing mood/depression, sexual dysfunction, disordered eating
    • Dietary or weight management initiatives for those diagnosed with T2DM or GDM
    • Annual care planning initiatives
    • Patient safety modules
    • Adapting best practice approaches for particular needs e.g. learning disabilities, other languages
    • Blood glucose management/monitoring initiatives
  • Innovations in prescribable diabetes therapies
  • Innovative practice models supporting accurate and timely diagnosis or improving management and outcomes of complications relating to type 2,  gestational and all other forms of diabetes e.g:
    • Short-term: hypoglycaemia, hyperosmolar hyperglycaemic state (HHS)
    • Long term: cardiovascular disease, ophthalmic complications, renal disease, autonomic or peripheral neuropathies, adverse pregnancy outcomes.

Judging Criteria and points: The judges will be focusing on the following areas when scoring your entry. Write your entry accordingly

Summary: provide background & brief overview of the initiative

5

Innovation: it is essential that applicants explain how their initiative is different and innovative compared with others e.g. novel approaches, creative solutions to longstanding problems, bridging gaps in care etc

20

Project planning: describe the identified need for the initiative. Organisation, stakeholders, planned timeframes and milestones. Evidence of clear, specific goals and outcome measures including reasoning behind these. How did you involve service users?

5

Methods: putting plans into action. What did you do? Describe how the initiative was implemented, and outline the procedures and tools you used to measure outcomes

10

Safety considerations: risk assessment, clinical governance, ethics and any other safety considerations and how these were successfully addressed

5

Effectiveness: demonstrate project effectiveness to illustrate efficiency improvement(s), how the initiative brought about change to support improved outcomes and what was the impact for people with diabetes?

15

Timeliness: did you achieve your goals in desired/required time frame?

5

User feedback: evidence of support from a range of interested stakeholders, e.g. healthcare professionals and/or service users. Please include statements. Describe how feedback was collected and bias was minimised. Provide examples of service user feedback and explain how this is used

15

Cost efficiency and economic viability: evidence of, and maximising quality health outcomes and minimising NHS costs, getting better value from the NHS budget

10

Sustainability and evidence for sharing practice and dissemination:
(1) Detail of potential or secured commitment to the initiative including length of plan, resources, stakeholders, funding sources
(2) For demonstrable sustainability, describe integration, compatibility, barriers encountered, evaluation and milestones
(3) For achieved spread of initiative to wider geographical areas or other healthcare setting, include details of strategy, communication of outcomes, key messages, objectives and evaluation undertaken.

10

Remember: entries without results will not be judged

Don’t forget: provide a copy of any previous submission(s) for this work


Quality In Care Diabetes

  • 2020 KEY DATES TO BE ANNOUNCED
QiC Diabetes is partnered by:
Supported by: